characteristics.text: SAMN40702589
characteristics.characteristic: External Id
characteristics.text: Hangzhou red cross hospital
characteristics.characteristic: INSDC center name
characteristics.text: 2025-07-01T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-07-01T20:51:01.886Z
characteristics.characteristic: INSDC last update
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Human
characteristics.characteristic: NCBI submission model
characteristics.text: Human.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: ERS27347175
characteristics.characteristic: SRA accession
characteristics.text: 57
characteristics.characteristic: age
characteristics.text: shanshan wang
characteristics.characteristic: biomaterial_provider
characteristics.text: Huh7 cell
characteristics.characteristic: cell_line
characteristics.text: 2017-03-30
characteristics.characteristic: collection_date
characteristics.text: control
characteristics.characteristic: description
characteristics.text: China: Hangzhou
characteristics.characteristic: geo_loc_name
characteristics.text: sorafenib resistant cells-1
characteristics.characteristic: isolate
characteristics.text: WSS4-R2
characteristics.characteristic: number
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: cell culture
characteristics.characteristic: sample_type
characteristics.text: male
characteristics.characteristic: sex
characteristics.text: liver
characteristics.characteristic: tissue
characteristics.text: huh7-res-1-R2
characteristics.characteristic: title
characteristics.text: continuous administration of gradually increasing sorafenib concentration over 4 months
characteristics.characteristic: treatment